Centre Hospitalier Universitaire Sart-Tilman

Liège 4000

0 studies enrolling now · 6 studies all time

What they study most

Active Idiopathic Inflammatory Myopathy, Antibody-mediated Rejection, Antisynthetase Syndrome, Breast Cancer, Dermatomyositis, HIV Infections, Idiopathic Pulmonary Fibrosis, Immune-Mediated Necrotizing Myopathy, Metastatic Breast Cancer, Myositis, Non Small Cell Lung Cancer, Polymyositis

Studies at this site

• A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy. — Completed
• A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer — Running, not enrolling
• A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer — Running, not enrolling
• Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients — Stopped early
• Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis — Completed
• A Comparison of Two Ways to Manage Anti-HIV Treatment (The SMART Study) — Completed